Nanomedicine‐Driven Modulation of Reductive Stress for Cancer Therapy
Advanced Science · 2025-08 · 12 (32)
DOI: 10.1002/advs.202501968 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Science, online erschienen am 26.06.2025. Verfasst von Yumin Mao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Materials Science and State Key Laboratory of Molecular Engineering of Polymers, Academy for Engineering and Technology, Fudan Universi…. Hauptthemen laut MEDLINE: Nanomedicine, Neoplasms, Oxidative Stress. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 192 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China Youth Fund, Key Program of National Natural Science Foundation of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
Redox balance is crucial for cellular function and adaptation to environmental changes, with its disruption playing a key role in the progression of various diseases, including cancer. While oxidative stress caused by excessive reactive oxygen species (ROS) has been widely studied and targeted in cancer therapies, such approaches face significant challenges within the tumor microenvironment. On the opposite end, reductive stress results from an overabundance of reducing equivalents, disrupting normal ROS‐dependent signaling pathways and leading to cellular dysfunction. Despite its importance in tumor biology, reductive stress has received less attention than oxidative stress. This group has deliberately driven tumors into a state of reductive stress, thereby exposing unique vulnerabilities and validating a novel therapeutic strategy. Here, the concept and mechanisms of reductive stress is reviewed, introduced methods for detecting it, and discussed its dual role in tumor progression and potential as a therapeutic target. Recent advances in nanomedicine, particularly in the design of functional nanomaterials, enabling precise modulation of cellular redox states are also highlighted. By selectively inducing reductive stress within tumors, nanomedicine offers a promising strategy to exploit tumor vulnerabilities, overcome drug resistance, and improve cancer therapy efficacy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Materials Science and State Key Laboratory of Molecular Engineering of Polymers, Academy for Engineering and Technology, Fudan University, Shanghai, 200433, P. R. China.
- Institute of Hepatobiliary and Pancreatic Surgery, Department of Hepatobiliary and Pancreatic Surgery, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, 200120, P. R. China.
ORCID-Profile: Wenbo Bu
Förderung
- National Natural Science Foundation of China Youth Fund
- Key Program of National Natural Science Foundation of China
- National Natural Science Foundation of China
- Shanghai Science and Technology Innovation Action Plan
Zitieren
APA
Mao, Y., Liu, X., Chu, X., Chen, F., Shi, R., Liu, Z., Wu, Y., Liu, Y., & Bu, W. (2025). Nanomedicine‐Driven Modulation of Reductive Stress for Cancer Therapy. Advanced Science, 12(32). https://doi.org/10.1002/advs.202501968
Vancouver
Mao Y, Liu X, Chu X, Chen F, Shi R, Liu Z, et al. Nanomedicine‐Driven Modulation of Reductive Stress for Cancer Therapy. Advanced Science. 2025;12(32). doi:10.1002/advs.202501968
BibTeX
@article{Mao2025,
author = {Mao, Yumin and Liu, Xianping and Chu, Xu and Chen, Feixiang and Shi, Ruicheng and Liu, Zonghao and Wu, Yelin and Liu, Yanyan and Bu, Wenbo},
title = {Nanomedicine‐Driven Modulation of Reductive Stress for Cancer Therapy},
journal = {Advanced Science},
year = {2025},
volume = {12},
number = {32},
doi = {10.1002/advs.202501968}
}
EUVIMED